SG Americas Securities LLC Purchases Shares of 1,132,208 Doximity, Inc. (NASDAQ:DOCS)

SG Americas Securities LLC purchased a new stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 1,132,208 shares of the company's stock, valued at approximately $65,702,000. SG Americas Securities LLC owned about 0.61% of Doximity at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. QSV Equity Investors LLC increased its stake in Doximity by 0.3% in the 4th quarter. QSV Equity Investors LLC now owns 60,763 shares of the company's stock worth $3,244,000 after buying an additional 186 shares during the period. Handelsbanken Fonder AB raised its holdings in Doximity by 0.7% in the 4th quarter. Handelsbanken Fonder AB now owns 29,700 shares of the company's stock worth $1,586,000 after purchasing an additional 200 shares during the period. Fielder Capital Group LLC raised its position in shares of Doximity by 4.5% during the 4th quarter. Fielder Capital Group LLC now owns 5,488 shares of the company's stock worth $293,000 after purchasing an additional 235 shares during the last quarter. Larson Financial Group LLC boosted its stake in shares of Doximity by 49.4% in the fourth quarter. Larson Financial Group LLC now owns 756 shares of the company's stock worth $40,000 after acquiring an additional 250 shares during the last quarter. Finally, Steward Partners Investment Advisory LLC lifted its stake in shares of Doximity by 17.1% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 2,269 shares of the company's stock worth $121,000 after buying an additional 332 shares in the last quarter. Hedge funds and other institutional investors own 87.19% of the company's stock.

Insider Transactions at Doximity

In related news, Director Kira Scherer Wampler sold 2,000 shares of Doximity stock in a transaction that occurred on Monday, June 2nd. The shares were sold at an average price of $52.89, for a total value of $105,780.00. Following the transaction, the director now directly owns 16,618 shares of the company's stock, valued at $878,926.02. This trade represents a 10.74% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Anna Bryson sold 45,000 shares of the stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $57.23, for a total transaction of $2,575,350.00. Following the completion of the transaction, the chief financial officer now directly owns 357,165 shares of the company's stock, valued at $20,440,552.95. This trade represents a 11.19% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 51,000 shares of company stock worth $2,900,770. 37.40% of the stock is owned by company insiders.

Doximity Price Performance

Shares of Doximity stock traded down $1.04 on Friday, hitting $55.92. 1,284,854 shares of the company's stock traded hands, compared to its average volume of 2,136,908. The stock has a market capitalization of $10.50 billion, a PE ratio of 55.92, a price-to-earnings-growth ratio of 4.10 and a beta of 1.32. The firm's 50-day moving average price is $55.13 and its two-hundred day moving average price is $58.43. Doximity, Inc. has a one year low of $25.00 and a one year high of $85.21.

Doximity (NASDAQ:DOCS - Get Free Report) last issued its quarterly earnings results on Thursday, May 15th. The company reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.11. Doximity had a net margin of 36.60% and a return on equity of 21.75%. During the same quarter in the previous year, the company posted $0.25 earnings per share. The firm's revenue for the quarter was up 17.1% compared to the same quarter last year. On average, analysts forecast that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

DOCS has been the subject of several analyst reports. Needham & Company LLC dropped their price target on shares of Doximity from $82.00 to $67.00 and set a "buy" rating for the company in a research note on Friday, May 16th. Canaccord Genuity Group dropped their price objective on Doximity from $71.00 to $50.00 and set a "hold" rating on the stock in a report on Friday, May 16th. JPMorgan Chase & Co. reduced their target price on shares of Doximity from $63.00 to $60.00 and set a "neutral" rating for the company in a report on Tuesday, May 27th. William Blair reissued an "outperform" rating on shares of Doximity in a research note on Friday, May 16th. Finally, Mizuho reduced their target price on shares of Doximity from $65.00 to $60.00 and set a "neutral" rating for the company in a research note on Friday, May 16th. Eleven analysts have rated the stock with a hold rating, nine have given a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $62.84.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.